Williams Jones & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Williams Jones & Associates's LLY Position: Q2 2019 in Review
Williams Jones & Associates reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2019, selling an estimated $36.2K and leaving 11,981 shares worth $1.33M. The position accounts for 0.03% of the portfolio, ranked #177.
Williams Jones & Associates first reported a position in LLY in Q2 2015 and has held it in 17 quarters since. The position peaked at $1.59M in Q1 2019. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.
- Williams Jones & Associates held 11,981 shares of Eli Lilly worth $1.33M as of Q2 2019.
- Williams Jones & Associates sold 307 Eli Lilly shares in Q2 2019, an estimated $36.2K.
- Eli Lilly made up 0.03% of Williams Jones & Associates's portfolio in Q2 2019, its #177 holding.
- Williams Jones & Associates first reported a position in Eli Lilly in Q2 2015 and has held it in 17 quarters since.
- Williams Jones & Associates's Eli Lilly position peaked at $1.59M in Q1 2019.
- 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.
Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.